Literature DB >> 8682506

Novel rhodopsin mutation in an autosomal dominant retinitis pigmentosa family: phenotypic variation in both heterozygote and homozygote Val137Met mutant patients.

C Ayuso1, M J Trujillo, M Robledo, C Ramos, J Benitez, F Martín-Osés, T del Rio, B García-Sandoval.   

Abstract

A family affected with autosomal dominant retinitis pigmentosa (RP) is presented. Two clinically affected patients (mother and daughter) were heterozygous for the same novel missense mutation (Val137Met) of the rhodopsin gene (RHO). Both heterozygous and homozygous cases were observed among their few symptomatic relatives. Wide clinical variation was exhibited among the individuals with mutations in this family. None of the controls showed this change in RHO, nor has it been previously reported in other RP families. No other RHO mutation was observed. Additional genetic or environmental factors could play a role in modulating the penetrance and clinical expression of this RHO mutation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682506     DOI: 10.1007/s004390050158

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

1.  Coupling of Human Rhodopsin to a Yeast Signaling Pathway Enables Characterization of Mutations Associated with Retinal Disease.

Authors:  Benjamin M Scott; Steven K Chen; Nihar Bhattacharyya; Abdiwahab Y Moalim; Sergey V Plotnikov; Elise Heon; Sergio G Peisajovich; Belinda S W Chang
Journal:  Genetics       Date:  2018-12-04       Impact factor: 4.562

2.  Genetic modifier loci of mouse Mfrp(rd6) identified by quantitative trait locus analysis.

Authors:  Jungyeon Won; Jeremy R Charette; Vivek M Philip; Timothy M Stearns; Weidong Zhang; Jürgen K Naggert; Mark P Krebs; Patsy M Nishina
Journal:  Exp Eye Res       Date:  2013-11-04       Impact factor: 3.467

Review 3.  Genetic modifiers as relevant biological variables of eye disorders.

Authors:  Kacie J Meyer; Michael G Anderson
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

4.  Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa.

Authors:  James W Kijas; Artur V Cideciyan; Tomas S Aleman; Michael J Pianta; Susan E Pearce-Kelling; Brian J Miller; Samuel G Jacobson; Gustavo D Aguirre; Gregory M Acland
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

5.  An allele of microtubule-associated protein 1A (Mtap1a) reduces photoreceptor degeneration in Tulp1 and Tub Mutant Mice.

Authors:  Dennis M Maddox; Sakae Ikeda; Akihiro Ikeda; Weidong Zhang; Mark P Krebs; Patsy M Nishina; Jürgen K Naggert
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-26       Impact factor: 4.799

6.  Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial.

Authors:  Dennis R Hoffman; Dianna K Hughbanks-Wheaton; N Shirlene Pearson; Gary E Fish; Rand Spencer; Alison Takacs; Martin Klein; Kirsten G Locke; David G Birch
Journal:  JAMA Ophthalmol       Date:  2014-07       Impact factor: 7.389

7.  Xenopus laevis P23H rhodopsin transgene causes rod photoreceptor degeneration that is more severe in the ventral retina and is modulated by light.

Authors:  Rui Zhang; Ericka Oglesby; Nicholas Marsh-Armstrong
Journal:  Exp Eye Res       Date:  2008-01-12       Impact factor: 3.467

8.  The severity of retinal degeneration in Rp1h gene-targeted mice is dependent on genetic background.

Authors:  Qin Liu; Alexei Saveliev; Eric A Pierce
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-05       Impact factor: 4.799

9.  Misfolded rhodopsin mutants display variable aggregation properties.

Authors:  Megan Gragg; Paul S-H Park
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-06-08       Impact factor: 5.187

10.  Role of a Dual Splicing and Amino Acid Code in Myopia, Cone Dysfunction and Cone Dystrophy Associated with L/M Opsin Interchange Mutations.

Authors:  Scott H Greenwald; James A Kuchenbecker; Jessica S Rowlan; Jay Neitz; Maureen Neitz
Journal:  Transl Vis Sci Technol       Date:  2017-05-10       Impact factor: 3.283

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.